Trial NCT01624493

View at ClinicalTrials.gov 
Org. Study IDs: GYN12-154 / ANZGOG-1103

Last trial update was posted on 2015-12-23

MeSH Interventions

Carboplatin Gemcitabine

MeSH Conditions

Carcinoma, Ovarian Epithelial Hypersensitivity Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

Phase I was conducted Australia. Phase II not conducted and no US pts enrolled.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID